Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan D Richman

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2020
In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal CancerSudhir B Malla, David J Fisher, Enric Domingo, et al.
Gut|April 28, 2022
Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancerShania M Corry, Amy Mb McCorry, Tamsin Rm Lannagan, et al.
Nature Genetics|February 14, 2024
Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancerSudhir B Malla, Ryan M Byrne, Maxime W Lafarge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2023
Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal CancerChristopher J M Williams, Faye Elliott, Nancy Sapanara, et al.
Cancer Cell|August 31, 2023
Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric studySophia J Wagner, Daniel Reisenbüchler, Nicholas P West, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2020
In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal CancerSudhir B Malla, David J Fisher, Enric Domingo, et al.
Gut|April 28, 2022
Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancerShania M Corry, Amy Mb McCorry, Tamsin Rm Lannagan, et al.
Nature Genetics|February 14, 2024
Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancerSudhir B Malla, Ryan M Byrne, Maxime W Lafarge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2023
Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal CancerChristopher J M Williams, Faye Elliott, Nancy Sapanara, et al.
Cancer Cell|August 31, 2023
Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric studySophia J Wagner, Daniel Reisenbüchler, Nicholas P West, et al.
Pageof 5